CRIS Current Research Information System

FAROLFI, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.834
NA - Nord America 2.070
EU - Europa 1.480
SA - Sud America 159
AF - Africa 153
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.018
VN - Vietnam 734
CN - Cina 696
SG - Singapore 691
IT - Italia 450
DE - Germania 260
HK - Hong Kong 244
SE - Svezia 165
GB - Regno Unito 137
IN - India 119
BR - Brasile 107
KR - Corea 101
FR - Francia 84
FI - Finlandia 81
RU - Federazione Russa 62
BD - Bangladesh 59
NL - Olanda 57
IE - Irlanda 55
CI - Costa d'Avorio 53
CA - Canada 35
ZA - Sudafrica 31
JO - Giordania 30
JP - Giappone 30
TH - Thailandia 27
PH - Filippine 23
BG - Bulgaria 22
TG - Togo 22
AR - Argentina 21
TR - Turchia 21
SC - Seychelles 19
AT - Austria 18
CH - Svizzera 14
ID - Indonesia 14
UA - Ucraina 14
MX - Messico 13
PL - Polonia 12
BE - Belgio 11
TW - Taiwan 11
IQ - Iraq 9
CL - Cile 7
CO - Colombia 7
EE - Estonia 6
PK - Pakistan 6
TN - Tunisia 6
EC - Ecuador 5
ES - Italia 5
NG - Nigeria 5
EG - Egitto 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BO - Bolivia 3
HR - Croazia 3
MA - Marocco 3
MY - Malesia 3
PE - Perù 3
PT - Portogallo 3
RO - Romania 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
DK - Danimarca 2
DZ - Algeria 2
KZ - Kazakistan 2
LT - Lituania 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AZ - Azerbaigian 1
BY - Bielorussia 1
CG - Congo 1
CZ - Repubblica Ceca 1
FJ - Figi 1
GM - Gambi 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
KE - Kenya 1
LB - Libano 1
LV - Lettonia 1
MG - Madagascar 1
MT - Malta 1
MU - Mauritius 1
NI - Nicaragua 1
PF - Polinesia Francese 1
QA - Qatar 1
RE - Reunion 1
RS - Serbia 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
YT - Mayotte 1
Totale 6.699
Salva come PNG Salva come JPEG
Città #
Singapore 496
Ashburn 296
Hong Kong 226
Hefei 205
Ho Chi Minh City 172
San Jose 151
Hanoi 132
Santa Clara 131
Chandler 122
Fairfield 118
Munich 109
Southend 99
Bologna 96
Seoul 95
Beijing 67
Helsinki 66
Los Angeles 64
Dublin 54
Abidjan 53
Princeton 53
Houston 52
Woodbridge 52
Dallas 51
Seattle 49
Boardman 45
New York 44
Wilmington 44
Milan 43
Dong Ket 40
Lauterbourg 39
Cambridge 36
Amman 29
Ann Arbor 24
Council Bluffs 24
Haiphong 24
Tongling 24
Lomé 22
Buffalo 21
Da Nang 21
São Paulo 21
Bengaluru 20
Berlin 20
Nuremberg 20
Shanghai 19
Sofia 19
Tokyo 19
Guangzhou 18
Johannesburg 18
Rome 18
Turin 18
Redondo Beach 17
Florence 16
San Diego 15
Chicago 14
Orem 14
Westminster 14
Redmond 13
Amsterdam 12
Des Moines 12
Bangkok 11
Brussels 11
Istanbul 11
Montreal 11
Bern 10
London 10
Phoenix 10
Toronto 10
Frankfurt am Main 9
Philadelphia 9
Kuban 8
Mumbai 8
Vienna 8
Biên Hòa 7
Boydton 7
Can Tho 7
Changsha 7
Chennai 7
Jinan 7
Long Xuyen 7
Modena 7
Redwood City 7
Shijiazhuang 7
Thái Nguyên 7
Warsaw 7
Yubileyny 7
Ankara 6
Bắc Giang 6
Bến Tre 6
Denver 6
Hyderabad 6
Hải Dương 6
Jakarta 6
Lappeenranta 6
Nanjing 6
Quận Bình Thạnh 6
Rimini 6
Rio de Janeiro 6
San Francisco 6
Tianjin 6
Brooklyn 5
Totale 4.132
Salva come PNG Salva come JPEG
Nome #
PSMA PET for the Evaluation of Liver Metastases in Castration-Resistant Prostate Cancer Patients: A Multicenter Retrospective Study 318
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence 271
A case of [68Ga]Ga-FAPI-46-avid and [18F]F-FDG-negative COVID-19 pneumonia sequelae 270
Adult patients with intellectual disability and epilepsy: clinical and genetic study of 114 cases 250
68Ga-PSMA-11 PET/CT in recurrent prostate cancer: efficacy in different clinical stages of PSA failure after radical therapy. 229
Identification of PET/CT radiomic signature for classification of locally recurrent rectal cancer: A network-based feature selection approach 226
Prediction Nomogram for 68 Ga-PSMA-11 PET/CT in Different Clinical Settings of PSA Failure After Radical Treatment for Prostate Cancer 225
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer. 204
Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection 195
FDG-PET assessment and metabolic patterns in Lafora disease 189
Incidental detection of basaloid thymic carcinoma with 68 Ga-PSMA-11 PET/CT in recurrent prostate cancer patient 183
FDG-PET findings and alcohol-responsive myoclonus in a patient with Unverricht-Lundborg disease 181
Evaluation of an Automated Module Synthesis and a Sterile Cold Kit-Based Preparation of 68Ga-PSMA-11 in Patients with Prostate Cancer. 170
[68Ga]Ga-PSMA-11 PET/CT-Positive Hepatic Inflammatory Pseudotumor: Possible PSMA-Avid Pitfall in Nuclear Imaging. 166
A step towards a multidisciplinary interpretative algorithm for indeterminate adrenal lesions: the value of visual and semi-quantitative 18F-FDG PET/CT and ceCT parameters 163
68 Ga-PSMA-11 Positron Emission Tomography Detects Residual Prostate Cancer After Prostatectomy in a Multicenter Retrospective Study 160
Negative 11C-choline PET/computed tomography imaging in restaging of patients with prostate cancer with serum prostate-specific antigen values >20 ng/mL. 159
Incidental finding of [68Ga]Ga-PSMA-avid intraductal papillary mucinous neoplasm 159
Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer. 158
Lung uptake detected by 68Ga-PSMA-11 PET/CT in prostate cancer patients with SARS-CoV-2: a case series. 146
The maximum standardized uptake value in patients with recurrent or persistent prostate cancer after radical prostatectomy and PSMA-PET-guided salvage radiotherapy-a multicenter retrospective analysis 140
Single Subcutaneous Prostate Cancer Metastasis Detected by 68 Ga-PSMA PET/CT During Early Biochemical Relapse: A Case Report 140
FDG-PET/CT Guided Biopsy in Angiosarcoma of Bone: Diagnosis, Staging and Beyond. 139
Mapping Prostate Cancer Lesions Before and After Unsuccessful Salvage Lymph Node Dissection Using Repeat PSMA PET. 136
Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions 134
Identification of PCWG3 Target Populations Is More Accurate and Reproducible with PSMA PET Than with Conventional Imaging: A Multicenter Retrospective Study. 133
Evaluating [68Ga]-Ga PSMA PET/CT for Detecting Prostate Cancer Recurrence Post-High-Intensity Focused Ultrasound and Brachytherapy: A Single-Center Retrospective Study. 129
Association of CSF and PET markers of neurodegeneration with electroclinical progression in Lafora disease 128
Male Breast Cancer Detected by 68Ga-PSMA-11 PET/CT in a Patient With Prostate Cancer With Pelvic Lymph Node Metastasis. 128
Plasma androgen receptor in prostate cancer 122
The Prognostic Role of 68GA-PSMA-PET/CT in Metastatic Hormone-Sensitive Prostate Cancer: A Preliminary Analysis 117
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology 113
null 113
Molecular Imaging and Theranostics-A Multidisciplinary Approach 110
Frontal predominant encephalopathy with early paligraphia as a distinctive signature of CAR T-cell therapy-related neurotoxicity 110
Metastasis-Free Survival and Patterns of Distant Metastatic Disease After Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA-PET)-Guided Salvage Radiation Therapy in Recurrent or Persistent Prostate Cancer After Prostatectomy 109
Multicenter External Validation of a Nomogram for Predicting Positive Prostate-specific Membrane Antigen/Positron Emission Tomography Scan in Patients with Prostate Cancer Recurrence 102
The role of prostate-specific membrane antigen PET/computed tomography in the management of prostate cancer patients: could we ask for more? 92
Highlights From 2017: Impactful Topics Published in the Annals of Nuclear Medicine 90
PET/CT Variants and Pitfalls in Prostate Cancer: What You Might See on PET and Should Never Forget. 87
Diagnostic Accuracy of 68Ga-PSMA-11 PET for Pelvic Nodal Metastasis Detection Prior to Radical Prostatectomy and Pelvic Lymph Node Dissection: A Multicenter Prospective Phase 3 Imaging Trial 86
Augmented Reality PSMA-3D guided robotic pelvic lymph node dissection (PLND) in prostate cancer patients 71
Non-oncologic incidental uptake on FAPI PET/CT imaging 68
PET imaging in urology: a rapidly growing successful collaboration. 61
Positron Emission Tomography and Whole-body Magnetic Resonance Imaging for Metastasis-directed Therapy in Hormone-sensitive Oligometastatic Prostate Cancer After Primary Radical Treatment: A Systematic Review. 58
Paraneoplastic hypocalcemia-induced heart failure in advanced breast cancer: A case report and literature review 53
Refining prognostic stratification in salvage radiotherapy for prostate cancer: a retrospective multicenter cohort study using PSMA-PET and machine learning 38
Totale 6.829
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202182 0 0 0 0 0 0 0 0 0 0 0 82
2021/2022610 102 18 21 59 41 26 16 46 35 33 141 72
2022/2023638 45 79 34 46 54 49 31 57 129 14 62 38
2023/2024318 25 39 26 20 28 80 12 16 23 18 20 11
2024/20251.436 76 119 113 89 177 79 142 77 71 87 115 291
2025/20263.204 331 416 266 253 267 155 393 100 559 233 146 85
Totale 6.829